Oncolytics Completes Patient Enrolment in Phase II Trial Of Reolysin For Colorectal Cancer Treatment
Oncolytics Biotech Inc. recently announced it completed patient enrollment in its randomized Phase 2 study of Reolysin to treat patients suffering with metastatic or advanced colorectal cancer. This trial is being sponsored and conducted by ... Read more